| Fifth Consecutive Quarter of Revenue Growth SOUTH SAN FRANCISCO, Calif., Nov. 9, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the third quarter of 2011. Total revenues for the quarter ended September 30, 2011 were $4.4 million, representing 38% growth over total revenues of ...continued DDXS |
Wednesday, November 9, 2011
diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment